Morioka T, Takeuchi M, Ozeki A, Emoto M, et al. A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN). Diabetes Obes Metab 2024 May 7. doi: 10.1111/dom.15644.
PMID: 38715179